Loading
Wearable-based early detection for cardiac arrhythmia
Intermittent arrhythmias routinely went undetected by short clinical monitoring windows, leading to preventable cardiac events.
A continuous wearable monitor paired with an FDA-cleared detection model that flags dangerous arrhythmia patterns in real time.
“PP Ventures pushed us to get FDA clearance before we scaled sales — the harder, slower, correct path.”
Noa Shapiro
Founder & CEO, Pulsepoint Diagnostics
12,000+
Patients Monitored
340
Events Flagged Early
19
Team Size